Bill106th CongressFiled Apr 13, 2000Health
H.Res. 477
Expressing the sense of the House of Representatives regarding the disparity between identical prescription drugs sold in the United States, Canada, and Mexico.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it does
A plain-language summary from the Congressional Research Service isn’t available yet for this bill. CRS summaries are typically posted within a few weeks of introduction.
What just happenedApr 24, 2000
Referred to the Subcommittee on Health and Environment.
Who’s behind it
Rep. Baldacci, John Elias [D-ME-2](D-ME)Sponsor
1committees4actions9subjects
- Introduced in HouseApr 13, 2000